Pavel Printsev serves as the Director of Business Development at Bridge Biotherapeutics. Prior to joining the company in early 2021 he was working at a South Korean venture capital firm with a focus on biotechnology. His professional journey began in the field of Organic Chemistry, where he initially worked as a Research Scientist. Over time, Pavel transitioned into roles that encompassed research planning and business development, leveraging his scientific expertise to foster growth and innovation. Throughout his career, Pavel has been instrumental in promoting scientific advancement through the establishment of global partnerships, collaborations, and investments. His efforts have been particularly focused on bridging South Korea with the international community, aiming to create a more interconnected and collaborative global scientific landscape.